AR037062A1 - Vacuna adn adyuvada y utilizacion de un compuesto elegido entre los polimeros del acido acrilico o metacrilico y los copolimeros de anhidrido maleico y de derivado alquenilo para adyuvar a dicha vacuna adn - Google Patents
Vacuna adn adyuvada y utilizacion de un compuesto elegido entre los polimeros del acido acrilico o metacrilico y los copolimeros de anhidrido maleico y de derivado alquenilo para adyuvar a dicha vacuna adnInfo
- Publication number
- AR037062A1 AR037062A1 ARP990101458A ARP990101458A AR037062A1 AR 037062 A1 AR037062 A1 AR 037062A1 AR P990101458 A ARP990101458 A AR P990101458A AR P990101458 A ARP990101458 A AR P990101458A AR 037062 A1 AR037062 A1 AR 037062A1
- Authority
- AR
- Argentina
- Prior art keywords
- virus
- feline
- disease
- dna vaccine
- vaccine according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Reivindicación 1: Vacuna ADN que comprende un ADN desnudo que incorpora y expresa in vivo una secuencia nucleotídica que codifica para un polipéptido antigénico, de preferencia un gen de un agente patógeno, y al menos un compuesto coadyudante elegido entre los polímeros acrílico o metacrílico y los copolímeros de anhídrido maleico y de derivado alquenilo. Reivindicación 2: Vacuna conforme a la reivindicación 1, caracterizada porque comprende como compuesto coadyudante un polímero del ácido acrílico o metacrílico reticulado por un éter polialquenílico de azúcar o de polialcohol Reivindicación 3: Vacuna conforme a la reivindicación 2, caracterizada porque el polímero es reticulado por un alilsacarosa o por alilpentaeritritol. Reivindicación 5: Vacuna conforme a alguna de las reivindicaciones 1 a 4, indistintamente, caracterizada porque el compuesto coadyudante está presente en la vacuna a razón de 0,01 % a 2 % P/V. Reivindicación 7: Vacuna conforme a alguna de las reivindicaciones 1 a 6, indistintamente, caracterizada porque el ADN desnudo es un plásmido Reivindicación 9: Vacuna conforme a la reivindicación 8, caracterizada porque comprende al menos una secuencia de un patógeno elegido entre: virus de la enfermedad de Aujeszky, virus de la gripe porcina, virus de la enfermedad misteriosa del cerdo, virus de la parvovirosis porcina, virus de la peste porcina clásica, Actinobacilus pleuropneumoniae, virus de la rinopneumonía equina, virus de la gripe equina, Cl. tetani, virus de la encefalitis del este, virus de la encefalitis del oeste, virus de la encefalitis venezolana, B. burgdorferi, virus de la enfermedad de Carré, parvovirus canino, coronavirus canino, virus herpes canino, virus de la rabia, virus herpes bovino de tipo 1 o 5, virus respiratorio sincitial bovino, pestivirus bovina, virus parainfluenza bovina de tipo 3, virus de la leucemia felina, virus de la panleucopenia felina, virus de la peritonitis infecciosa felina, herpevirus felino, virus de la calicivirosis felina, virus de la inmunodeficiencia felina, virus de la enfermedad de Marek, virus de la enfermedad de Newcastle, virus de la enfermedad de Gumboro, virus de la bronquitis infecciosa de las aves, virus de la anemia infecciosas de las aves, virus de la laringotraqueitis infecciosa, virus de la leucosis de las aves, pneumovirus de las aves, virus de la peste de las aves.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9804409A FR2776928B1 (fr) | 1998-04-03 | 1998-04-03 | Vaccins adn adjuves |
Publications (1)
Publication Number | Publication Date |
---|---|
AR037062A1 true AR037062A1 (es) | 2004-10-20 |
Family
ID=9525029
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP990101458A AR037062A1 (es) | 1998-04-03 | 1999-03-31 | Vacuna adn adyuvada y utilizacion de un compuesto elegido entre los polimeros del acido acrilico o metacrilico y los copolimeros de anhidrido maleico y de derivado alquenilo para adyuvar a dicha vacuna adn |
Country Status (17)
Country | Link |
---|---|
US (1) | US7163926B1 (es) |
EP (1) | EP1066055B1 (es) |
JP (1) | JP2002510651A (es) |
AR (1) | AR037062A1 (es) |
AT (1) | ATE353670T1 (es) |
AU (1) | AU744964B2 (es) |
BR (1) | BR9909342A (es) |
CA (1) | CA2327389C (es) |
CY (1) | CY1108013T1 (es) |
DE (1) | DE69935136T2 (es) |
DK (1) | DK1066055T3 (es) |
ES (1) | ES2283105T3 (es) |
FR (1) | FR2776928B1 (es) |
PL (1) | PL194348B1 (es) |
PT (1) | PT1066055E (es) |
WO (1) | WO1999051269A1 (es) |
ZA (1) | ZA992478B (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6551598B2 (en) | 2000-01-21 | 2003-04-22 | Merial | Vaccination against canine herpesvirosis and vaccines therefor |
FR2804026B1 (fr) * | 2000-01-21 | 2004-06-11 | Merial Sas | Vaccination contre l'herpesvirose canine et vaccins |
CA2470322A1 (en) * | 2001-12-14 | 2003-06-26 | Genetronics, Inc. | Methods for particle-assisted polynucleotide immunization using a pulsed electric field |
US7959929B2 (en) | 2005-04-21 | 2011-06-14 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
US11865172B2 (en) | 2005-04-21 | 2024-01-09 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
US7682619B2 (en) | 2006-04-06 | 2010-03-23 | Cornell Research Foundation, Inc. | Canine influenza virus |
UA100370C2 (uk) | 2006-12-11 | 2012-12-25 | Мериал Лимитед | Спосіб вакцинації птахів проти salmonella |
CL2008001806A1 (es) | 2007-06-20 | 2008-09-05 | Wyeth Corp | Composicion de vacuna en emulsion agua en aceite que comprende un antigeno y un adyuvante en la fase acuosa; y metodo de elaboracion. |
GB0805356D0 (en) * | 2008-03-25 | 2008-04-30 | Isis Innovation | Vaccine adjuvant composition |
MX2010012069A (es) | 2008-05-08 | 2010-12-14 | Merial Ltd | Vacuna de la leishmaniasis con el uso del inmunogeno salival de la mosca de la arena. |
US8168200B2 (en) * | 2008-10-24 | 2012-05-01 | Merial Limited | Vaccine against african horse sickness virus |
LT2734230T (lt) | 2011-07-20 | 2019-03-25 | Merial Limited | Rekombinantinė kačių leikemijos viruso vakcina, turinti optimizuotą kačių leukemijos viruso apvalkalo geną |
US20130177591A1 (en) | 2012-01-10 | 2013-07-11 | Merial Limited | Lipid Based Adjuvants for DNA Plasmids |
WO2013142371A1 (en) | 2012-03-20 | 2013-09-26 | Merial Limited | Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein c and uses thereof |
CA2883296A1 (en) | 2012-08-30 | 2014-03-06 | Merial, Inc. | Hyperbaric device and methods for producing inactivated vaccines and for refolding/solubilizing recombinant proteins |
WO2016210097A1 (en) * | 2015-06-23 | 2016-12-29 | The Trustees Of Columbia University In The City Of New York | Novel equine parvovirus and uses thereof |
CN109475615B (zh) | 2016-06-17 | 2023-04-07 | 勃林格殷格翰动物保健美国公司 | 包含直链或支链聚丙烯酸聚合物佐剂的新免疫原性制剂 |
MX2023000097A (es) * | 2020-07-07 | 2023-02-09 | Amyris Inc | Adyuvantes de vacunas y metodos de sintetizacion y uso de estos. |
CN114272368A (zh) * | 2021-12-16 | 2022-04-05 | 成都博宠生物科技有限公司 | 一种猪瘟和猪伪狂犬二联疫苗及其制备方法和应用 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3920811A (en) * | 1972-12-22 | 1975-11-18 | Cutter Lab | Adjuvant compositions |
CA1267087A (en) * | 1985-02-14 | 1990-03-27 | Nicolaas Visser | Synthetic immunogen |
ZA881694B (en) * | 1987-03-17 | 1988-09-06 | Akzo N.V. | Adjuvant mixture |
US6004563A (en) * | 1990-11-07 | 1999-12-21 | American Home Products Corporation | Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same |
EP0532833A1 (en) * | 1991-05-28 | 1993-03-24 | Miles Inc. | Vaccine for equine rhinopneumonitis |
EP0655072B1 (en) * | 1992-06-01 | 2004-02-11 | The University Of Melbourne | Immunological method for the detection of antibodies to equine herpesvirus type 1 and 4 glycoprotein G |
WO1995011700A1 (en) * | 1993-10-29 | 1995-05-04 | Pharmos Corp. | Submicron emulsions as vaccine adjuvants |
BE1008977A5 (fr) * | 1994-12-27 | 1996-10-01 | Solvay | Adjuvants pour vaccins. |
US6300118B1 (en) * | 1995-06-07 | 2001-10-09 | American Home Products Corporation | Plasmids comprising a genetically altered feline immunodeficiency virus genome |
US5820869A (en) * | 1995-06-07 | 1998-10-13 | American Home Products Corporation | Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
FR2751226B1 (fr) * | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies du cheval |
GB9623051D0 (en) * | 1996-11-06 | 1997-01-08 | Schacht Etienne H | Delivery of DNA to target cells in biological systems |
US6406705B1 (en) * | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
EP0991767A1 (en) * | 1997-06-11 | 2000-04-12 | Institut Pasteur | Attenuated recombinant mycobacteria useful as immunogens or as vaccine components |
AU8392898A (en) * | 1997-07-14 | 1999-02-10 | Powerject Vaccines, Inc. | Method of dna vaccination using dna encoding antigen and encoding il6 |
GB9726398D0 (en) * | 1997-12-12 | 1998-02-11 | Isis Innovation | Polypeptide and coding sequences |
US6444799B1 (en) * | 1997-12-31 | 2002-09-03 | Csl Limited | P. gingivalis polynucleotides and uses thereof |
-
1998
- 1998-04-03 FR FR9804409A patent/FR2776928B1/fr not_active Expired - Lifetime
-
1999
- 1999-03-22 WO PCT/FR1999/000666 patent/WO1999051269A1/fr active IP Right Grant
- 1999-03-22 AT AT99909069T patent/ATE353670T1/de active
- 1999-03-22 DE DE69935136T patent/DE69935136T2/de not_active Expired - Lifetime
- 1999-03-22 ES ES99909069T patent/ES2283105T3/es not_active Expired - Lifetime
- 1999-03-22 EP EP99909069A patent/EP1066055B1/fr not_active Expired - Lifetime
- 1999-03-22 AU AU28448/99A patent/AU744964B2/en not_active Expired
- 1999-03-22 CA CA2327389A patent/CA2327389C/en not_active Expired - Lifetime
- 1999-03-22 DK DK99909069T patent/DK1066055T3/da active
- 1999-03-22 PT PT99909069T patent/PT1066055E/pt unknown
- 1999-03-22 JP JP2000542039A patent/JP2002510651A/ja active Pending
- 1999-03-22 BR BR9909342-1A patent/BR9909342A/pt not_active Application Discontinuation
- 1999-03-22 PL PL99343602A patent/PL194348B1/pl unknown
- 1999-03-31 ZA ZA9902478A patent/ZA992478B/xx unknown
- 1999-03-31 AR ARP990101458A patent/AR037062A1/es unknown
-
2000
- 2000-10-02 US US09/677,672 patent/US7163926B1/en not_active Expired - Lifetime
-
2007
- 2007-05-09 CY CY20071100615T patent/CY1108013T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA2327389A1 (en) | 1999-10-14 |
WO1999051269A1 (fr) | 1999-10-14 |
DK1066055T3 (da) | 2007-06-11 |
JP2002510651A (ja) | 2002-04-09 |
ZA992478B (en) | 2000-10-10 |
PL194348B1 (pl) | 2007-05-31 |
FR2776928A1 (fr) | 1999-10-08 |
US7163926B1 (en) | 2007-01-16 |
PL343602A1 (en) | 2001-08-27 |
ATE353670T1 (de) | 2007-03-15 |
EP1066055A1 (fr) | 2001-01-10 |
ES2283105T3 (es) | 2007-10-16 |
CY1108013T1 (el) | 2013-09-04 |
PT1066055E (pt) | 2007-05-31 |
DE69935136T2 (de) | 2007-11-29 |
FR2776928B1 (fr) | 2000-06-23 |
AU744964B2 (en) | 2002-03-07 |
AU2844899A (en) | 1999-10-25 |
DE69935136D1 (de) | 2007-03-29 |
BR9909342A (pt) | 2000-12-12 |
CA2327389C (en) | 2011-06-14 |
EP1066055B1 (fr) | 2007-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR037062A1 (es) | Vacuna adn adyuvada y utilizacion de un compuesto elegido entre los polimeros del acido acrilico o metacrilico y los copolimeros de anhidrido maleico y de derivado alquenilo para adyuvar a dicha vacuna adn | |
AR008620A1 (es) | Vacuna viva recombinante, fragmento de adn y virus iltv que la componen | |
ES2291029T3 (es) | Clones infecciosos del virus de la enfermedad de newcastle, vacunas y analisis diagnosticos. | |
CY1118963T1 (el) | Βιολογικα συστηματα μεταφορας πολλαπλου-συστατικου | |
KR100687509B1 (ko) | 고양이과 동물의 폴리뉴클레오티드 백신 제제 | |
CA3102950A1 (en) | Modified guide rnas for gene editing | |
RU2007103151A (ru) | Вакцинная композиция, содержащая иммуностимулирующие олигодезоксинуклеотиды | |
AR010102A1 (es) | VACUNA VIVA RECOMBINANTE AVIARIA QUE COMPRENDE CoMO VECTOR UN VIRUS ILTV QUE COMPRENDE Y EXPRESA AL MENOS UNA SECUENCIA NUCLEOTíDICAHETERoLOGA | |
AR059828A2 (es) | Formula de vacuna para equidos, su utilizacion y kit de vacunacion | |
AR007862A1 (es) | Vacuna bovina, su uso y kit de vacunación que la contiene. | |
CN1225685A (zh) | 禽多核苷酸疫苗制剂 | |
CO4650231A1 (es) | Vacuna viva recombinante aviaria que utiliza como vector el virus de laringotraqueitis infecciosa aviaria | |
CY1105109T1 (el) | Διαδικασια για την παρασκευη μικρου μοριακου βαρους πολυαιθυλενιμινης | |
RU2016103695A (ru) | СВЯЗАННАЯ С РЕСПИРАТОРНЫМ ЗАБОЛЕВАНИЕМ ГЕН-СПЕЦИФИЧЕСКАЯ миРНК, ДВУСПИРАЛЬНАЯ КОНСТРУКЦИЯ ОЛИГО-РНК, СОДЕРЖАЩАЯ миРНК, И СОДЕРЖАЩАЯ ЕЕ КОМПОЗИЦИЯ ДЛЯ ПРЕДУПРЕЖДЕНИЯ ИЛИ ЛЕЧЕНИЯ РЕСПИРАТОРНОГО ЗАБОЛЕВАНИЯ | |
PL190615B1 (pl) | Kompozycja szczepionki dla świń, zastosowanie kompozycji szczepionki, zestaw do szczepienia, szczepionka dla świń i zastosowanie plazmidu | |
AR076767A1 (es) | Procedimiento para provocar una respuesta inmunitaria reforzada en especies aviares | |
DE69634698D1 (de) | Gewebespezifische und ziel-rna-spezifische ribozyme | |
Li et al. | A recombinant canine distemper virus expressing a modified rabies virus glycoprotein induces immune responses in mice | |
AR014127A1 (es) | Produccion de lignina siringilica en gimnospermas | |
CO5300406A1 (es) | Vacuna | |
EP0954582A1 (en) | Polynucleotide vaccine against canine distemper | |
MXPA02001009A (es) | Virus de la influenza atenuado util como vacuna. | |
ECSP972164A (es) | Vacunas de uso aviario a base de virus de laringotraqueitis infecciosa | |
Troyer et al. | rVSV-BASED COVID VACCINE FOR THE PREVENTION OF BREAKTHROUGH SARS-CoV-2 INFECTIONS | |
JP2017518264A (ja) | Rnaの細胞内送達のための、キャップされた及びキャップされていないrna分子およびブロックコポリマー |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |